Clinical Trials Browser

OTHER × Disease Progression × avelumab × Clear all

NCT03990571 2024-10-18

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Phase 2 Completed

40 enrolled 13 charts

Carcinoma, Adenoid Cystic, Disease Progression